[go: up one dir, main page]

MX338863B - Metodo de obtencion de extracto dializable de leucocitos. - Google Patents

Metodo de obtencion de extracto dializable de leucocitos.

Info

Publication number
MX338863B
MX338863B MX2011013852A MX2011013852A MX338863B MX 338863 B MX338863 B MX 338863B MX 2011013852 A MX2011013852 A MX 2011013852A MX 2011013852 A MX2011013852 A MX 2011013852A MX 338863 B MX338863 B MX 338863B
Authority
MX
Mexico
Prior art keywords
obtaining
leukocyte extract
dialyzable leukocyte
dialyzable
extract
Prior art date
Application number
MX2011013852A
Other languages
English (en)
Other versions
MX2011013852A (es
Inventor
Sergio Estrada Parra
Iris Citlali Elvira Etrada García
Sonia Mayra Pérez Tapia
Original Assignee
Inst Politecnico Nacional
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Politecnico Nacional filed Critical Inst Politecnico Nacional
Priority to MX2011013852A priority Critical patent/MX338863B/es
Priority to CA2860260A priority patent/CA2860260C/en
Priority to EP12857547.9A priority patent/EP2792685B1/en
Priority to PL12857547T priority patent/PL2792685T3/pl
Priority to PCT/MX2012/000129 priority patent/WO2013089550A1/es
Priority to PE2014000969A priority patent/PE20141566A1/es
Priority to LTEP12857547.9T priority patent/LT2792685T/lt
Priority to DK12857547.9T priority patent/DK2792685T3/en
Priority to RS20181105A priority patent/RS57821B1/sr
Priority to US14/365,849 priority patent/US9328152B2/en
Priority to SI201231393T priority patent/SI2792685T1/sl
Priority to BR112014014671-3A priority patent/BR112014014671B1/pt
Priority to PT12857547T priority patent/PT2792685T/pt
Priority to SM20180502T priority patent/SMT201800502T1/it
Priority to ES12857547.9T priority patent/ES2688318T3/es
Priority to HUE12857547A priority patent/HUE039451T2/hu
Publication of MX2011013852A publication Critical patent/MX2011013852A/es
Priority to CL2014001584A priority patent/CL2014001584A1/es
Priority to GT201400117A priority patent/GT201400117A/es
Priority to CO14138326A priority patent/CO7230340A2/es
Publication of MX338863B publication Critical patent/MX338863B/es
Priority to HRP20181501TT priority patent/HRP20181501T1/hr
Priority to CY20181100986T priority patent/CY1121260T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere a un proceso para la producción de factor de transferencia. Este proceso consiste de las etapas de congelación y descongelación de leucocitos de sangre periférica, diálisis, ultrafiltración tangencial, identificación y cuantificación por cromatografía líquida de ultraresolución por exclusión molecular, y validación biológica in vitro. El producto de este proceso es útil para su aplicación médica.
MX2011013852A 2011-12-16 2011-12-16 Metodo de obtencion de extracto dializable de leucocitos. MX338863B (es)

Priority Applications (21)

Application Number Priority Date Filing Date Title
MX2011013852A MX338863B (es) 2011-12-16 2011-12-16 Metodo de obtencion de extracto dializable de leucocitos.
PT12857547T PT2792685T (pt) 2011-12-16 2012-12-17 Método para obter um extrato dialisável de leucócitos
BR112014014671-3A BR112014014671B1 (pt) 2011-12-16 2012-12-17 Processo para produzir um fator de transferência e produto
PL12857547T PL2792685T3 (pl) 2011-12-16 2012-12-17 Sposób otrzymywania dializowalnego ekstraktu leukocytów
PCT/MX2012/000129 WO2013089550A1 (es) 2011-12-16 2012-12-17 Método de obtención de extracto dializable de leucocitos
PE2014000969A PE20141566A1 (es) 2011-12-16 2012-12-17 Metodo de obtencion de extracto dializable de leucocitos
LTEP12857547.9T LT2792685T (lt) 2011-12-16 2012-12-17 Dializuojamo leukocitų ekstrakto gavimo būdas
DK12857547.9T DK2792685T3 (en) 2011-12-16 2012-12-17 PROCEDURE FOR OBTAINING A DIALYZEABLE LEUKOCYT EXTRACT
RS20181105A RS57821B1 (sr) 2011-12-16 2012-12-17 Postupak za dobijanje dijalizabilnog ekstrakta leukocita
US14/365,849 US9328152B2 (en) 2011-12-16 2012-12-17 Method for obtaining a dialyzable leukocyte extract
SM20180502T SMT201800502T1 (it) 2011-12-16 2012-12-17 Metodo per ottenere un estratto di leucociti dializzabile
CA2860260A CA2860260C (en) 2011-12-16 2012-12-17 Method for obtaining a dialyzable leukocyte dializable extract
EP12857547.9A EP2792685B1 (en) 2011-12-16 2012-12-17 Method for obtaining a dialyzable leukocyte extract
SI201231393T SI2792685T1 (sl) 2011-12-16 2012-12-17 Metoda za pridobivanje ekstrakta levkocita za dializo
ES12857547.9T ES2688318T3 (es) 2011-12-16 2012-12-17 Método de obtención de extracto dializable de leucocitos
HUE12857547A HUE039451T2 (hu) 2011-12-16 2012-12-17 Eljárás dializálható leukocita kivonat elõállítására
CL2014001584A CL2014001584A1 (es) 2011-12-16 2014-06-16 Metodo de obtencion de extracto dializable de leucocitos
GT201400117A GT201400117A (es) 2011-12-16 2014-06-16 Metodo de obtención de extracto dualizable de leucocitos
CO14138326A CO7230340A2 (es) 2011-12-16 2014-06-26 Método de obtención de extracto dializable de leucitos
HRP20181501TT HRP20181501T1 (hr) 2011-12-16 2018-09-20 Postupak dobivanja dijalizabilnog ekstrakta leukocita
CY20181100986T CY1121260T1 (el) 2011-12-16 2018-09-25 Μεθοδος για ληψη ενος διαπιδυσιμου εκχυλισματος λευκοκυτταρων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011013852A MX338863B (es) 2011-12-16 2011-12-16 Metodo de obtencion de extracto dializable de leucocitos.

Publications (2)

Publication Number Publication Date
MX2011013852A MX2011013852A (es) 2013-09-05
MX338863B true MX338863B (es) 2016-05-01

Family

ID=48612894

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011013852A MX338863B (es) 2011-12-16 2011-12-16 Metodo de obtencion de extracto dializable de leucocitos.

Country Status (21)

Country Link
US (1) US9328152B2 (es)
EP (1) EP2792685B1 (es)
BR (1) BR112014014671B1 (es)
CA (1) CA2860260C (es)
CL (1) CL2014001584A1 (es)
CO (1) CO7230340A2 (es)
CY (1) CY1121260T1 (es)
DK (1) DK2792685T3 (es)
ES (1) ES2688318T3 (es)
GT (1) GT201400117A (es)
HR (1) HRP20181501T1 (es)
HU (1) HUE039451T2 (es)
LT (1) LT2792685T (es)
MX (1) MX338863B (es)
PE (1) PE20141566A1 (es)
PL (1) PL2792685T3 (es)
PT (1) PT2792685T (es)
RS (1) RS57821B1 (es)
SI (1) SI2792685T1 (es)
SM (1) SMT201800502T1 (es)
WO (1) WO2013089550A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108129549B (zh) * 2017-12-19 2020-06-05 浙江丰安生物制药有限公司 一种脾氨肽内多肽的提取方法
PE20231510A1 (es) * 2020-12-09 2023-09-26 Inst Politecnico Nacional Composicion de peptidos para inmunoterapia

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system
DE3244607A1 (de) 1982-12-02 1984-06-07 Bezirksblutspendezentrale Plauen, DDR 9900 Plauen Verfahren zur herstellung von humanen transfer-faktor-praeparaten
US4816563A (en) 1983-11-25 1989-03-28 Amtron, Inc. Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof
CH0225254H1 (en) 1985-11-25 1998-09-15 Ghen Corp Specific antibody-containing substance from eggs and method of production and use thereof
WO1992000093A1 (en) 1990-07-02 1992-01-09 National Jewish Center For Immunology And Respiratory Medicine Transfer factor and methods of use
MX9504215A (es) * 1995-10-05 1997-04-30 Inst Politecnico Nacional Procedimiento mejorado para la purificacion de oligopeptidos con pesos moleculares de 1000 a 10,000 daltones, a partir de estractos leucocitos y su presentacion farmaceutica.
US5883224A (en) 1996-04-19 1999-03-16 Cytokine Sciences, Inc. Characterization of transfer factors and methods of use
US20020044942A1 (en) 2000-09-18 2002-04-18 Chisolm Biological Laboratory, Llc Transfer factor composition and process for producing same
US6468534B1 (en) 2000-09-21 2002-10-22 4Life Research, Lc Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use
US10471100B2 (en) * 2006-09-29 2019-11-12 4Life Patents, Llc Nanofraction immune modulators, preparations and compositions including the same, and associated methods
CZ299296B6 (cs) * 2006-06-13 2008-06-11 Sevapharma A.S. Lécivo transfer faktor - zpusob výroby a použití

Also Published As

Publication number Publication date
LT2792685T (lt) 2018-10-25
BR112014014671A2 (pt) 2017-06-13
HRP20181501T1 (hr) 2018-11-16
PT2792685T (pt) 2018-10-26
PE20141566A1 (es) 2014-11-26
MX2011013852A (es) 2013-09-05
BR112014014671B1 (pt) 2022-05-10
WO2013089550A1 (es) 2013-06-20
PL2792685T3 (pl) 2019-03-29
SMT201800502T1 (it) 2018-11-09
US9328152B2 (en) 2016-05-03
GT201400117A (es) 2019-08-02
HUE039451T2 (hu) 2018-12-28
SI2792685T1 (sl) 2018-11-30
CO7230340A2 (es) 2015-03-31
CA2860260C (en) 2019-02-12
CA2860260A1 (en) 2013-06-20
EP2792685A4 (en) 2015-05-06
EP2792685A1 (en) 2014-10-22
ES2688318T3 (es) 2018-10-31
RS57821B1 (sr) 2018-12-31
CY1121260T1 (el) 2020-05-29
DK2792685T3 (en) 2018-10-08
CL2014001584A1 (es) 2015-04-24
US20140357840A1 (en) 2014-12-04
EP2792685B1 (en) 2018-06-27

Similar Documents

Publication Publication Date Title
Gross et al. Therapeutic strategies in fragile X syndrome: from bench to bedside and back
WO2012149299A3 (en) Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
EP3106087B8 (en) For estimating extracorporeal blood volume and for counting surgical samples
HK1218613A1 (zh) 用於測量連續無創血壓 的體佩式系統
DK3311827T3 (da) Nanopartikler, fremgangsmåde til fremstilling og anvendelse deraf som bærere for amfipatiske eller hydrofobe molekyler inden for det medicinske område, inklusiv cancerbehandling, samt fødevarerelaterede forbindelser
WO2012135573A3 (en) Systems and methods for varying blood flow to identify autoregulatory ranges in a patient
WO2014004990A3 (en) Methods for determining drug efficacy using cereblon-associated proteins
EP2809810A4 (en) SYSTEM AND METHOD FOR DETECTING CANNED RNAS IN PERIPHERAL BLOOD
EP2741806A4 (en) METHOD AND APPARATUS FOR BLOOD DIALYSIS
EP2825099A4 (en) SYSTEM AND METHOD FOR FEEDING BODY TISSUE
MX2014000753A (es) Procedimiento para producir antigeno viral y vacunas.
WO2014048411A3 (de) Pumpe, system mit einer blutpumpe und verfahren zur herstellung einer blutpumpe
HK1201225A1 (en) Single stage filtration system and method for use with blood processing systems
MX338863B (es) Metodo de obtencion de extracto dializable de leucocitos.
EP3025737A4 (en) Blood purification membrane, method for manufacturing blood purification membrane, and dialysis device
MX2013003168A (es) Anticuerpo contra ephrin b2 y su uso.
MX2011013853A (es) Proceso de produccion de factor de transferencia.
CR20130577A (es) Producto de proteínas y proceso para la fabricación de un producto de proteínas a partir de exudado de carne cruda
GB201020300D0 (en) Product
WO2012120438A3 (en) Systems and methods for use in molecular drug design
WO2012084996A3 (en) Methods for identifying biologically active oligonucleotides capable of modulating the immune system
DK201370413A (en) Salmonid alphavirus protein e2
WO2014064542A3 (en) Micro-scale liquid-liquid-liquid extraction
UA106882C2 (uk) Спосіб біотехнологічного одержання гемодеривату з телячої крові
UA76883U (ru) Способ определения дельта-аминолевулиновой кислоты в сыворотке крови кур-несушек

Legal Events

Date Code Title Description
FG Grant or registration